Pulished Date August, 2019
ID: 107
Share on
Share on

Asia-pacific Nuclear Medicine Radiopharmaceuticals Market by Diagnostics, by Therapeutics, by Application and by Country( India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2019-2024)

Pulished: August, 2019
ID: 107
Pages: 145

Asia-Pacific nuclear medicine Radiopharmaceuticals Size & Growth (2019 - 2024)

The Asia-pacific market for Nuclear Medicine Radiopharmaceuticals is estimated at $1.25 billion in 2019 and is expected to reach $2.43 billion by 2024, growing at a CAGR of 14.3%.

Nuclear medicine falls under the field of Molecular imaging, which involves the usage of minute amounts of radioactive material (radiopharmaceuticals) to diagnose and treat disease.

Drivers and Restraints

Increasing incidence of chronic diseases such as cancer and cardiac ailments, advancements in technology, increasing demand for SPECT and PET applications along with the growing public awareness for healthcare are fuelling the growth of the market. Further, new developments such as the Integration of X-ray tomography (CT) into SPECT provide an excellent diagnostic tool in medical imaging and are considered to be a driving factor for the growth of the market. A strict regulatory framework poses a potential hurdle to translational research and clinical investigations. Reimbursement issues are also blocking the growth of the market. In addition, shorter half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are the key factors restraining the Asia-Pacific nuclear medicine Radioisotopes market.

India and China hold a potential market for radioisotope due to rising healthcare and increasing demand for different radioisotopes in various treatments and applications.

Diagnostic Radioisotopes is the dominating segment and accounts for around 90 % of the radiopharmaceuticals market while therapeutic radioisotopes contribute 10% of the market. Based on the type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18, Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcomes of these tracers have been gaining the business interest of major research institutes and PET isotope players in recent times. Ga-68 and Rb-82 are two other potential isotopes in the PET diagnostic market, ensuring the high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future PET radioisotopes market.

This research report segmented and sub-segmented into the following categories:

  • By Diagnostics: SPECT, PET
  • By Therapeutics: Beta Emitters, Alpha Emitters, Brachytherapy
  • by Application: cardiology, lymphoma, thyroid, neurology oncology
  • By Country: India, China, Japan, South Korea,  Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Leading companies in the Asia-Pacific nuclear medicine Radiopharmaceuticals:

  1. GE Healthcare
  2. Hologic Inc.
  3. Medix Inc.
  4. Segami Corporation
  5. Positron Corporation
  6. Bracco Imaging S.p.A
  7. Naviscan Inc.
  8. Bayer Healthcare
  9. Lantheus Medical Imaging, Inc.
  10. IBA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 China                                            

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                               

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  2. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  3. Asia-Pacific Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  4. Asia-Pacific Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  5. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  6. Asia-Pacific Cardiology Market By Region, From 2019-2024 (USD Million)
  7. Asia-Pacific Lymphoma Market By Region, From 2019-2024 (USD Million)
  8. Asia-Pacific Thyroid Market By Region, From 2019-2024 (USD Million)
  9. Asia-Pacific Neurology Market By Region, From 2019-2024 (USD Million)
  10. Asia-Pacific Oncology Market By Region, From 2019-2024 (USD Million)
  11. Asia-Pacific Other Applications Market By Region, From 2019-2024 (USD Million)
  12. Asia-Pacific Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  13. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  14. Asia-Pacific PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  15. Asia-Pacific Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  16. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  17. Asia-Pacific Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  18. Asia-Pacific Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  19. Asia-Pacific Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  20. Asia-Pacific Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  21. Asia-Pacific Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  22. Asia-Pacific PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  23. Asia-Pacific Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  24. Asia-Pacific Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  25. Asia-Pacific Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  26. Asia-Pacific Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  27. Asia-Pacific Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  28. Asia-Pacific Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  29. Asia-Pacific Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  30. Asia-Pacific Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  31. Asia-Pacific Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  32. Asia-Pacific Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  33. Asia-Pacific Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  34. Asia-Pacific Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  35. Asia-Pacific Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  36. Asia-Pacific Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  37. Asia-Pacific Radium-223 Market By Region, From 2019-2024 ( USD Million )
  38. Asia-Pacific Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  39. Asia-Pacific Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  40. Asia-Pacific Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  41. Asia-Pacific Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  42. Asia-Pacific Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  43. Asia-Pacific Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  44. China Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  45. China Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  46. India Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  47. India Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  48. Japan Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  49. Japan Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  50. South Korea Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  51. South Korea Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  52. China Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  53. India Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  54. Japan Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  55. South Korea Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  56. China SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  57. India SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  58. Japan SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  59. South Korea SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  60. China PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  61. India PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  62. Japan PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  63. South Korea PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  64. China Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  65. India Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  66. Japan Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  67. South Korea Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  68. China Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  69. India Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  70. Japan Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  71. South Korea Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  72. China Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  73. India Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  74. Japan Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  75. South Korea Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  76. China Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  77. India Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  78. Japan Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  79. South Korea Brachytherapy Market By Type, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample